Apple has awarded $10 million to a company that specializes in manufacturing sample collection kits for COVID-19 testing. Thanks to this support, COPAN Diagnostics will be able to ramp up their output to help supply a much larger number of kits to US hospitals – the aim is for a million kits per week by the start of July.
This investment was made from Apple’s Advanced Manufacturing Fund, which is usually spent supporting companies directly related to Apple’s manufacturing interests. Considering the current pandemic, Apple has decided to use the fund to help fight COVID-19. The money will help COPAN move to a larger facility, hire more staff, and upgrade its equipment.
The screening packs in question
“We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19,” said Jeff Williams, Apple’s chief operating officer. “COPAN is one of the world’s most innovative manufacturers of sample collection kits for COVID-19 testing, and we’re thrilled to partner with them so they can expand as we work to address this critical issue for our nation. I couldn’t be prouder of our teams for bringing all of their energy, passion, and innovative spirit to supporting the country’s COVID-19 response.”
COVID Screening Tool
If you missed it, Apple also released a COVID-19 app last week to use as a rudimentary screening tool. The app was created in partnership with the CDC and is intended to answer FAQs and provide general advice to lessen the strain on healthcare providers.
It can also help you check possible symptoms and advise on the extent that you should be social distancing in your given circumstances.
It’s a good way to keep track of up-to-date information from trusted sources – but it’s currently only available in the US.